Biopsy Devices: Technologies and Global Markets

Biopsy Devices: Technologies and Global Markets

Report Scope:

This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

Report Includes:

44 data tables and 21 additional tables

Detailed overview and an up-to-date analysis of the global market for biopsy devices

Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027

Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region

Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market

Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market

A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials

Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace

Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis

Patent grants and patent applications on biopsy devices and cancer diagnostics industry

Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.

Companies Mentioned

ARGON MEDICAL DEVICES INC.
B. BRAUN MELSUNGEN AG
BECTON, DICKINSON AND CO. (CAREFUSION CORP.)
BOSTON SCIENTIFIC CORP.
CARDINAL HEALTH INC.
CONMED CORP.
Cook Medical Inc.
DANAHER CORP. (MAMMOTOME)
DTR MEDICAL LTD.
FUJIFILM HOLDINGS CORP.
HOLOGIC INC.
INRAD INC.
MAUNA KEA TECHNOLOGIES
MDNA LIFE SCIENCES INC.
MDXHEALTH INC.
MEDTRONIC
MERIT MEDICAL SYSTEMS INC.
OLYMPUS CORP.